Antibacterial and Antiviral Coatings and Resins
Inhibit Coatings produces long lifetime antibacterial and antiviral technology to prevent the spread of dangerous pathogens.
Use of TMEM219 agonists for the treatment of cancer, metabolic syndrome, obstructive respiratory disorders and related diseases
The invention relates to compositions comprising IGFBP-3 receptor agonist monoclonal antibodies and methods for the treatment of cancers, metabolic syndrome, obstructive respiratory disorders and related diseases with IGFBP-3 receptor agonist monoclonal antibodies.